Amgen adds $300M to Puerto Rico budget; Novartis to exit oral drug factory in Germany

May 7, 2026 10:00 AM EDT Manufacturing Am­gen adds $300M to Puer­to Ri­co bud­get; No­var­tis to ex­it oral drug fac­to­ry in Ger­many ENDPOINTS Plus, news about FDA’s one-day in­spec­tions and Bio­MADE: 🇵🇷 Am­gen pours an­oth­er $300M in­to Puer­to Ri­co: The funds will be used Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER